Two of the drug makers facing the largest number of personal injury suits have opted to settle during the last year rather than go through extended litigation. Bayer Corp. has resolved approximately 9,200 claims alleging injuries from its birth control pills Yasmin and Yaz while Boehringer Ingelheim Pharmaceuticals Inc. agreed to a master settlement resolving 4,590 claims against its blood thinner Pradaxa (dabigatran).
It is unclear if these cases reflect a trend toward early settlement as other companies have chosen to spend many years and millions of dollars defending their products in court
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?